The open-reading-frame 3a of SARS coronavirus (SARS-CoV) had been demonstrated previously to form a cation-selective channel that may become expressed in the infected cell and is then involved in virus release. Drugs that inhibit the ion channel formed by the 3a protein can be expected to inhibit virus release, and would be a source for the development of novel therapeutic agents. Here we demonstrate that emodin can inhibit the 3a ion channel of coronavirus SARS-CoV and HCoV-OC43 as well as virus release from HCoV-OC43 with a K1/2 value of about 20 M. We suggest that viral ion channels, in general, may be a good target for the development of antiviral agents.
SEEK ID: https://fairdomhub.org/publications/497
DOI: 10.1016/j.antiviral.2011.02.008
Projects: COVID-19 Disease Map
Publication type: Journal
Journal: Antiviral Research
Citation: Antiviral Research 90(1):64-69
Date Published: 1st Apr 2011
URL: https://linkinghub.elsevier.com/retrieve/pii/S0166354211000465
Registered Mode: imported from a bibtex file
Views: 939
Created: 8th Apr 2020 at 20:13
Last updated: 8th Dec 2022 at 17:26
This item has not yet been tagged.
None